Verastem IncNASDAQ:VSTM
- LAST PRICE3.2500
- TODAY'S CHANGE (%)-0.0200 (-0.6116%)
- Bid / Lots3.1600/ 3
- Ask / Lots3.3800/ 12
- Open / Previous Close3.3000 / 3.2700
- Day Range
- 52 Week Range
- Volume625,656
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VSTM |
|---|---|---|
| 09:32 ET | 9711 | 3.21 |
| 09:34 ET | 1700 | 3.2 |
| 09:36 ET | 6758 | 3.22 |
| 09:38 ET | 901 | 3.2247 |
| 09:39 ET | 105 | 3.22 |
| 09:41 ET | 10631 | 3.21 |
| 09:43 ET | 438 | 3.21 |
| 09:45 ET | 3295 | 3.21 |
| 09:48 ET | 1400 | 3.21 |
| 09:50 ET | 30196 | 3.17 |
| 09:52 ET | 1500 | 3.1601 |
| 09:54 ET | 13141 | 3.15 |
| 09:56 ET | 5166 | 3.155 |
| 09:57 ET | 2977 | 3.1501 |
| 09:59 ET | 2643 | 3.16 |
| 10:01 ET | 4809 | 3.17 |
| 10:03 ET | 2800 | 3.18 |
| 10:06 ET | 401 | 3.1799 |
| 10:08 ET | 1586 | 3.1899 |
| 10:10 ET | 1329 | 3.16 |
| 10:12 ET | 1366 | 3.1574 |
| 10:15 ET | 3898 | 3.16 |
| 10:17 ET | 2100 | 3.165 |
| 10:19 ET | 1547 | 3.1789 |
| 10:21 ET | 1191 | 3.18 |
| 10:24 ET | 400 | 3.19 |
| 10:26 ET | 300 | 3.18 |
| 10:28 ET | 108 | 3.2 |
| 10:30 ET | 2200 | 3.22 |
| 10:32 ET | 2831 | 3.229 |
| 10:33 ET | 100 | 3.23 |
| 10:35 ET | 6910 | 3.23 |
| 10:37 ET | 20792 | 3.24 |
| 10:39 ET | 300 | 3.23 |
| 10:42 ET | 1500 | 3.2299 |
| 10:44 ET | 300 | 3.225 |
| 10:53 ET | 402 | 3.23 |
| 10:55 ET | 100 | 3.23 |
| 10:57 ET | 591 | 3.23 |
| 11:02 ET | 1873 | 3.23 |
| 11:04 ET | 809 | 3.24 |
| 11:06 ET | 982 | 3.25 |
| 11:08 ET | 500 | 3.25 |
| 11:09 ET | 267 | 3.255 |
| 11:11 ET | 500 | 3.245 |
| 11:13 ET | 200 | 3.23 |
| 11:15 ET | 720 | 3.24 |
| 11:18 ET | 400 | 3.24 |
| 11:20 ET | 300 | 3.23 |
| 11:24 ET | 7692 | 3.22 |
| 11:26 ET | 1000 | 3.23 |
| 11:27 ET | 346 | 3.23 |
| 11:31 ET | 512 | 3.23 |
| 11:36 ET | 144 | 3.23 |
| 11:38 ET | 1394 | 3.22 |
| 11:40 ET | 600 | 3.22 |
| 11:42 ET | 3827 | 3.24 |
| 11:44 ET | 1840 | 3.2596 |
| 11:47 ET | 1615 | 3.255 |
| 11:51 ET | 1569 | 3.255 |
| 11:54 ET | 100 | 3.2513 |
| 11:56 ET | 2647 | 3.2312 |
| 11:58 ET | 100 | 3.225 |
| 12:00 ET | 102 | 3.2214 |
| 12:03 ET | 100 | 3.2201 |
| 12:05 ET | 2502 | 3.2202 |
| 12:07 ET | 1330 | 3.224 |
| 12:09 ET | 902 | 3.215 |
| 12:12 ET | 564 | 3.22 |
| 12:14 ET | 100 | 3.2188 |
| 12:16 ET | 676 | 3.22 |
| 12:21 ET | 600 | 3.22 |
| 12:25 ET | 200 | 3.21 |
| 12:27 ET | 700 | 3.2111 |
| 12:32 ET | 1476 | 3.205 |
| 12:36 ET | 200 | 3.2 |
| 12:38 ET | 100 | 3.2 |
| 12:39 ET | 388 | 3.2 |
| 12:41 ET | 613 | 3.21 |
| 12:43 ET | 519 | 3.215 |
| 12:45 ET | 100 | 3.21 |
| 12:48 ET | 100 | 3.21 |
| 12:50 ET | 100 | 3.2 |
| 12:54 ET | 100 | 3.2 |
| 12:56 ET | 1000 | 3.2 |
| 01:01 ET | 100 | 3.19 |
| 01:03 ET | 100 | 3.19 |
| 01:08 ET | 1712 | 3.18 |
| 01:14 ET | 13990 | 3.15 |
| 01:15 ET | 3053 | 3.15 |
| 01:17 ET | 2129 | 3.145 |
| 01:19 ET | 204 | 3.15 |
| 01:21 ET | 410 | 3.1591 |
| 01:24 ET | 210 | 3.1518 |
| 01:26 ET | 100 | 3.15 |
| 01:28 ET | 7271 | 3.1552 |
| 01:30 ET | 1636 | 3.15 |
| 01:32 ET | 1724 | 3.15 |
| 01:33 ET | 5312 | 3.16 |
| 01:35 ET | 200 | 3.16 |
| 01:37 ET | 10206 | 3.16 |
| 01:39 ET | 100 | 3.17 |
| 01:46 ET | 104131 | 3.19 |
| 01:48 ET | 5946 | 3.18 |
| 01:50 ET | 14297 | 3.18 |
| 01:51 ET | 250 | 3.17 |
| 01:55 ET | 5788 | 3.19 |
| 01:57 ET | 1073 | 3.19 |
| 02:00 ET | 1900 | 3.17 |
| 02:02 ET | 1800 | 3.19 |
| 02:04 ET | 200 | 3.19 |
| 02:06 ET | 700 | 3.19 |
| 02:08 ET | 200 | 3.19 |
| 02:09 ET | 965 | 3.19 |
| 02:11 ET | 600 | 3.19 |
| 02:13 ET | 9900 | 3.2 |
| 02:15 ET | 12780 | 3.19 |
| 02:18 ET | 7097 | 3.205 |
| 02:20 ET | 100 | 3.205 |
| 02:22 ET | 100 | 3.205 |
| 02:24 ET | 200 | 3.21 |
| 02:26 ET | 400 | 3.21 |
| 02:27 ET | 400 | 3.21 |
| 02:29 ET | 472 | 3.21 |
| 02:31 ET | 1714 | 3.21 |
| 02:33 ET | 1301 | 3.22 |
| 02:36 ET | 1000 | 3.22 |
| 02:38 ET | 900 | 3.23 |
| 02:40 ET | 1000 | 3.225 |
| 02:42 ET | 700 | 3.225 |
| 02:44 ET | 500 | 3.23 |
| 02:45 ET | 1954 | 3.23 |
| 02:47 ET | 9438 | 3.22 |
| 02:49 ET | 453 | 3.226 |
| 02:51 ET | 959 | 3.225 |
| 02:54 ET | 2250 | 3.22 |
| 02:58 ET | 810 | 3.23 |
| 03:00 ET | 1715 | 3.21 |
| 03:02 ET | 100 | 3.22 |
| 03:03 ET | 900 | 3.21 |
| 03:05 ET | 4952 | 3.22 |
| 03:07 ET | 858 | 3.22 |
| 03:09 ET | 200 | 3.23 |
| 03:12 ET | 771 | 3.23 |
| 03:14 ET | 500 | 3.23 |
| 03:16 ET | 400 | 3.23 |
| 03:18 ET | 400 | 3.23 |
| 03:20 ET | 979 | 3.23 |
| 03:21 ET | 600 | 3.23 |
| 03:23 ET | 600 | 3.23 |
| 03:25 ET | 1320 | 3.22 |
| 03:27 ET | 800 | 3.22 |
| 03:30 ET | 1148 | 3.23 |
| 03:32 ET | 3476 | 3.225 |
| 03:34 ET | 1000 | 3.215 |
| 03:36 ET | 400 | 3.22 |
| 03:38 ET | 8702 | 3.21 |
| 03:39 ET | 100 | 3.22 |
| 03:41 ET | 100 | 3.2199 |
| 03:43 ET | 500 | 3.22 |
| 03:45 ET | 1200 | 3.22 |
| 03:48 ET | 9330 | 3.25 |
| 03:50 ET | 12950 | 3.26 |
| 03:52 ET | 16359 | 3.29 |
| 03:54 ET | 7830 | 3.285 |
| 03:56 ET | 11009 | 3.27 |
| 03:57 ET | 16082 | 3.27 |
| 03:59 ET | 5557 | 3.25 |
Yesterday
Jun 17, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM, from 7:52PM ET on Monday Jun 17, 2024 by Dow Jones
7:52PM ET on Monday Jun 17, 2024 by Dow Jones
Jun 15, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM, from 8:15AM ET on Saturday Jun 15, 2024 by Dow Jones
8:15AM ET on Saturday Jun 15, 2024 by Dow Jones
Jun 11, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM, from 4:16PM ET on Tuesday Jun 11, 2024 by Dow Jones
4:16PM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 10, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Verastem Inc | 82.8M | -0.7x | --- |
PMV Pharmaceuticals Inc | 82.8M | -1.2x | --- |
IO Biotech Inc | 82.4M | -0.7x | --- |
Connect Biopharma Holdings Ltd | 82.1M | -1.3x | --- |
Vor Biopharma Inc | 81.9M | -0.7x | --- |
Cognition Therapeutics Inc | 80.5M | -2.2x | --- |
Company Information
Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).
Contact Information
- Headquarters
- 117 Kendrick Street, Suite 500CAMBRIDGE, MA, United States 02494
- Phone
- 781-292-4200
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Daniel Paterson
- Chief Financial Officer
- Daniel Calkins
- Independent Director
- Paul Bunn
- Independent Director
- Anil Kapur
- Independent Director
- Michelle Robertson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $82.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 25.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.19 |
EPS | $-4.40 |
Book Value | $3.11 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
